About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in Los Angeles | 18 Studies

Clinical Trials Multiple SclerosisLos Angeles

Multiple Sclerosis Clinical Trials in Los Angeles

Find 18 clinical trials for multiple sclerosis near Los Angeles, California. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in Los Angeles

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-18 of 18 trials

TerminatedClinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)This clinical study compares the efficacy, safety, and tolerability of therapy with ponesimod vs placebo in subjects with active RMS who are treated with DMF (Tecfidera®).NCT02907177·Birmingham, Alabama and 118 others

Multiple Sclerosis Trials in Other Cities

New York Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingA Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) ElevationThis study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofatumumab versus staying on their…NCT05090371·Birmingham, Alabama and 42 others

CompletedTraditional Versus Early Aggressive Therapy for Multiple Sclerosis TrialFDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal impact once the progressive phase has begun.NCT03500328·Birmingham, Alabama and 46 others

CompletedSafety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple SclerosisThis is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study designed to evaluate the safety, tolerability and activity of ibudilast administered…NCT01982942·Birmingham, Alabama and 27 others

TerminatedPhase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple SclerosisThe purpose of this study is to evaluate the safety and tolerability of ATA188 as a monotherapy in Parts 1 and 2, to determine the recommended Part 2 dose (RP2D) of ATA188 as…NCT03283826·La Jolla, California and 30 others

CompletedCombination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRxThis is for a randomized clinical trial (RCT) to determine if the combined use of interferon beta-1a (IFN) and glatiramer acetate (GA) is a measurably better therapy than either…NCT00211887·Birmingham, Alabama and 70 others

Active not recruitingStudy to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)A study to evaluate the efficacy and safety of fenebrutinib on disability progression and relapse rate in adult participants with RMS.NCT04586023·Cullman, Alabama and 105 others

CompletedMetformin Treatment in Progressive Multiple SclerosisThe purpose of this study is to assess the safety of metformin for treatment of progressive multiple sclerosisNCT05349474·Los Angeles, California

Active not recruitingEfficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple SclerosisEfficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosisNCT04926818·Little Rock, Arkansas and 50 others

CompletedTestosterone Treatment for Multiple SclerosisSince men are less likely to develop multiple sclerosis, the hypothesis was that testosterone might be protective in MS. Men with MS for followed untreated for 6 months, followed…NCT00405353·Los Angeles, California

Active not recruitingEfficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple SclerosisThe purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the disability progression and the…NCT06141486·Homewood, Alabama and 310 others

UnknownEstriol Treatment in Multiple Sclerosis (MS): Effect on CognitionApproximately 50% of people diagnosed with Multiple Sclerosis (MS) will develop problems with cognition.NCT01466114·Los Angeles, California and 3 others

Active not recruitingSafety and Efficacy of Fingolimod in Pediatric Patients With Multiple SclerosisTo evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS)NCT01892722·Birmingham, Alabama and 72 others

RecruitingA Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisOrelabrutinib is a CNS-penetrable BTK inhibitor.NCT07299019·Phoenix, Arizona and 45 others

CompletedExercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple SclerosisMany persons with Multiple Sclerosis ( MS) have problems with memory and thinking.Exercise has been shown to improve memory and thinking in persons with diseases such as…NCT01219647·Los Angeles, California and 1 other

CompletedA Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)This is a double-blinded, placebo controlled study of estriol pills versus placebo pills in relapsing remitting multiple sclerosis.NCT00451204·Scottsdale, Arizona and 15 others

CompletedA Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)This study will evaluate the efficacy and safety of ocrelizumab in participants with RRMS who have had a suboptimal response to an adequate course of DMT.NCT02637856·Cullman, Alabama and 81 others

WithdrawnTestosterone for Fatigue in Men With MSFatigue is a major symptom in people with multiple sclerosis (MS), for which treatments are limited.NCT03000127·Los Angeles, California and 1 other

Other Conditions in Los Angeles

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia